View in EDS

KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.

Saved in:
Bibliographic Details
Title: KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
Authors: Sigafoos AN; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Tolosa EJ; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Carr RM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Barrena MG; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Almada LL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Pease DR; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Hogenson TL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Raja Arul GL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Mousavi F; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Sen S; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Vera RE; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Marks DL; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Flores LF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., LaRue-Nolan KC; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Wu C; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Bamlet WR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Vrabel AM; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota., Sicotte H; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Schenk EL; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Smyrk TC; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Zhang L; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Rabe KG; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Oberg AL; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota., Zaphiropoulos PG; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden., Chevet E; Université de Rennes, CEDEX, Rennes, France., Graham RP; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., Hagen CE; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota., di Magliano MP; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan., Elsawa SF; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire., Pin CL; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada., Mao J; University of Massachusetts Medical School, Worcester, Massachusetts., McWilliams RR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota., Fernandez-Zapico ME; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
Source: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1677-1689.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38896052
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sigafoos+AN%22">Sigafoos AN</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Tolosa+EJ%22">Tolosa EJ</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Carr+RM%22">Carr RM</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Fernandez-Barrena+MG%22">Fernandez-Barrena MG</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Almada+LL%22">Almada LL</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Pease+DR%22">Pease DR</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Hogenson+TL%22">Hogenson TL</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Raja+Arul+GL%22">Raja Arul GL</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Mousavi+F%22">Mousavi F</searchLink>; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Sen+S%22">Sen S</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Vera+RE%22">Vera RE</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Marks+DL%22">Marks DL</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Flores+LF%22">Flores LF</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22LaRue-Nolan+KC%22">LaRue-Nolan KC</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Wu+C%22">Wu C</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Bamlet+WR%22">Bamlet WR</searchLink>; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Vrabel+AM%22">Vrabel AM</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Sicotte+H%22">Sicotte H</searchLink>; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Schenk+EL%22">Schenk EL</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Smyrk+TC%22">Smyrk TC</searchLink>; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Zhang+L%22">Zhang L</searchLink>; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Rabe+KG%22">Rabe KG</searchLink>; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Oberg+AL%22">Oberg AL</searchLink>; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Zaphiropoulos+PG%22">Zaphiropoulos PG</searchLink>; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Chevet+E%22">Chevet E</searchLink>; Université de Rennes, CEDEX, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Graham+RP%22">Graham RP</searchLink>; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Hagen+CE%22">Hagen CE</searchLink>; Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22di+Magliano+MP%22">di Magliano MP</searchLink>; Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Elsawa+SF%22">Elsawa SF</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire.<br /><searchLink fieldCode="AU" term="%22Pin+CL%22">Pin CL</searchLink>; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Department of Oncology, University of Western Ontario, London, Canada.<br /><searchLink fieldCode="AU" term="%22Mao+J%22">Mao J</searchLink>; University of Massachusetts Medical School, Worcester, Massachusetts.<br /><searchLink fieldCode="AU" term="%22McWilliams+RR%22">McWilliams RR</searchLink>; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.<br /><searchLink fieldCode="AU" term="%22Fernandez-Zapico+ME%22">Fernandez-Zapico ME</searchLink>; Division of Oncology Research, Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1677-1689.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38896052
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2767-9764.CRC-23-0464
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1677
    Titles:
      – TitleFull: KRAS Promotes GLI2-Dependent Transcription during Pancreatic Carcinogenesis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sigafoos AN
      – PersonEntity:
          Name:
            NameFull: Tolosa EJ
      – PersonEntity:
          Name:
            NameFull: Carr RM
      – PersonEntity:
          Name:
            NameFull: Fernandez-Barrena MG
      – PersonEntity:
          Name:
            NameFull: Almada LL
      – PersonEntity:
          Name:
            NameFull: Pease DR
      – PersonEntity:
          Name:
            NameFull: Hogenson TL
      – PersonEntity:
          Name:
            NameFull: Raja Arul GL
      – PersonEntity:
          Name:
            NameFull: Mousavi F
      – PersonEntity:
          Name:
            NameFull: Sen S
      – PersonEntity:
          Name:
            NameFull: Vera RE
      – PersonEntity:
          Name:
            NameFull: Marks DL
      – PersonEntity:
          Name:
            NameFull: Flores LF
      – PersonEntity:
          Name:
            NameFull: LaRue-Nolan KC
      – PersonEntity:
          Name:
            NameFull: Wu C
      – PersonEntity:
          Name:
            NameFull: Bamlet WR
      – PersonEntity:
          Name:
            NameFull: Vrabel AM
      – PersonEntity:
          Name:
            NameFull: Sicotte H
      – PersonEntity:
          Name:
            NameFull: Schenk EL
      – PersonEntity:
          Name:
            NameFull: Smyrk TC
      – PersonEntity:
          Name:
            NameFull: Zhang L
      – PersonEntity:
          Name:
            NameFull: Rabe KG
      – PersonEntity:
          Name:
            NameFull: Oberg AL
      – PersonEntity:
          Name:
            NameFull: Zaphiropoulos PG
      – PersonEntity:
          Name:
            NameFull: Chevet E
      – PersonEntity:
          Name:
            NameFull: Graham RP
      – PersonEntity:
          Name:
            NameFull: Hagen CE
      – PersonEntity:
          Name:
            NameFull: di Magliano MP
      – PersonEntity:
          Name:
            NameFull: Elsawa SF
      – PersonEntity:
          Name:
            NameFull: Pin CL
      – PersonEntity:
          Name:
            NameFull: Mao J
      – PersonEntity:
          Name:
            NameFull: McWilliams RR
      – PersonEntity:
          Name:
            NameFull: Fernandez-Zapico ME
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2767-9764
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer research communications
              Type: main
ResultId 1